Orgenesis Enters into Collaboration Agreement with the Bambino Gesù Children's Hospital in Rome to Establish Point of Care Cell and Gene Therapy Center

Go back to Orgenesis Enters into Collaboration Agreement with the Bambino Gesù Children's Hospital in Rome to Establish Point of Care Cell and Gene Therapy Center
Orgenesis, Inc. NEW (NASDAQ: ORGS) Delayed: 5.66 +1.11 (24.40%)
Previous Close $4.55    52 Week High $0.52 
Open $5.51    52 Week Low $0.24 
Day High $5.91    P/E 113.20 
Day Low $4.91    EPS $0.05 
Volume 15,051,164